$glmd

Galmed Pharmaceuticals sees a surge in X engagement, driven by discussions around its strong financial health and a potential blockbuster drug. However, concerns linger over the stock price's performance relative to previous share sales.

About $glmd

Galmed Pharmaceuticals is a biopharmaceutical company.

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [---] -65%
[--] Month: [------] +27%
[--] Months: [-------] -41%
[--] Year: [---------] -38%
1-Year High: [-------] on 2025-11-17
1-Year Low: [--] on 2025-09-28

Engagements by network (24h): YouTube: [--] Reddit: [--] X: [---] TikTok: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-17
1-Year Low: [--] on 2025-09-23

Mentions by network (24h): YouTube: [--] Reddit: [--] X: [--] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $glmd in the last [--] hours which is up 47% from [--] in the previous [--] hours Daily Average: [--]
1-Year High: [---] on 2025-11-17
1-Year Low: [--] on 2025-09-23

Sentiment: 100%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 88%
[--] Week: 100% no change
[--] Month: 100% no change
[--] Months: 100% +25%
[--] Year: 100% +33%
1-Year High: 100% on 2025-02-18
1-Year Low: 29% on 2025-08-11

Most Supportive Themes:

Strong Balance Sheet and No Debt: (30%) The company's financial health is highlighted by its substantial cash reserves and lack of debt, making it an attractive investment.
Potential Billion Dollar Drug: (25%) The company is developing a drug with the potential for significant market success, indicating future growth prospects.

Most Critical Themes:

Stock Price vs. Share Price: (45%) The current stock price is significantly lower than the price at which shares were previously sold, raising concerns about investor returns.

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing